go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

sanofi-aventis

sanofi-aventis
Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 4035600
Fax: +353 1 4035687
Medical Information e-mail: IEmedinfo@sanofi-aventis.com


Summary of Product Characteristics last updated on medicines.ie: 18/07/2007
SPC Dioralyte

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Dioralyte Blackcurrant Powder for Oral Solution.

Dioralyte Citrus Powder for Oral Solution.

Dioralyte Natural Powder for Oral Solution.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each sachet contains:

Sodium Chloride 0.47g

Potassium Chloride 0.30g

Glucose 3.56g

Disodium Hydrogen Citrate 0.53g

Excipients:

Dioralyte Blackcurrant: Also includes ethanol, less than 100mg per dose.

Dioralyte Citrus: Also includes sulphur dioxide (E220)

For a full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Powder for oral solution.

White, homogeneous, granular powder with an odour and taste of blackcurrant.

White, homogeneous, granular powder with an odour and taste of lemon and lime.

White, homogeneous, granular powder.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

In the oral correction of fluid and electrolyte loss and in the management of watery diarrhoea.


Go to top of the page
4.2 Posology and method of administration

The basic unit of dosage is the content of a single sachet reconstituted in 200ml (approximately 7 fluid ounces) of drinking water. Use fresh drinking water for adults and children. For infants where drinking water is unavailable the water should be freshly boiled and cooled. The solution should be made up immediately before use. If refrigerated, the solution may be stored for up to 24 hours, otherwise any solution remaining an hour after reconstitution should be discarded.

The solution must not be boiled after reconstitution.

Daily intake may be based on a volume of 150ml/kg body weight for infants and 20-40 mg/kg body weight for adults and children. A reasonable approximation is:

Infants – One to one and a half times the usual feed volume. For infants under 12 months, use only under medical advice.

Children – One sachet after every loose motion.

Adults including elderly – One or two sachets after every loose motion. More may be required initially to ensure early and full volume repletion.


Go to top of the page
4.3 Contraindications

There are no known contra-indications to Dioralyte.


Go to top of the page
4.4 Special warnings and precautions for use

Special labelling requirements.

The solution must not be reconstituted except with water at the volume stated.

Solutions of greater concentration may result in hypernatraemia. Those of greater dilution may result in inadequate replacement.

If there is no improvement within 24-36 hours the physician should be consulted.

For infants under 12 months use only on medical advice.

If nausea and vomiting are present with the diarrhoea, small but frequent amounts of dioralyte should be drunk at first.

For use in the elderly no specific precautions are necessary. However, care should be taken when administering glucose-electrolyte solutions in cases of severe renal or hepatic impairment or other conditions where the normal electrolyte balance may be distributed.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None


Go to top of the page
4.6 Pregnancy and lactation

Dioralyte is not contra-indicated in pregnancy or lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

None.


Go to top of the page
4.8 Undesirable effects

None stated.


Go to top of the page
4.9 Overdose

In the event of significant overdose, serum electrolytes should be evaluated as soon as possible, appropriate steps taken to correct any abnormalities and levels monitored until return to normal levels is established. This is particularly important in the very young and in cases of severe hepatic or renal failure.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Dioralyte is an oral rehydration therapy. The combination of electrolytes stimulates water and electrolyte absorption from the gastro-intestinal tract and therefore prevents dehydration in diarrhoea.


Go to top of the page
5.2 Pharmacokinetic properties

Sodium and glucose are actively transported via the membrane into the enterocytes. Sodium is then extruded into the intercellular spaces and the resulting osmotic gradient causes water and electrolytes to be drawn from the gut and then into the circulation.


Go to top of the page
5.3 Preclinical safety data

None.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)

Dioralyte Blackcurrant

Colloidal Anhydrous Silica

Saccharin Sodium

Blackcurrant flavour

(contains ethanol)

Dioralyte Citrus

Colloidal Anhydrous Silica

Saccharin Sodium

Citrus flavour

(contains sulphur dioxide)

Dioralyte Natural

Colloidal Anhydrous Silica

Saccharin Sodium


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

2 years.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C. The reconstituted solution should be used immediately but may be stored for up to 24 hours in a refrigerator at 2-8°C.


Go to top of the page
6.5 Nature and contents of container

Foil/polyethylene laminate sachets containing powder for reconstitution packed in outer cartons.

Pack sizes: 3, 6, 7, 10, 14, 20, 30 Sachets.

Not all pack sizes may be marketed.


Go to top of the page
6.6 Special precautions for disposal and other handling

The solution should be prepared immediately before use.

The contents of each sachet should be dissolved in 200 ml (approximately 7 fluid ounces) of drinking/cooled boiled water where relevant. Dioralyte should only be prepared with water and to the volume stated.

The solution must not be boiled after reconstitution.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

sanofi-aventis Ireland Ltd.,

Citywest Business Campus,

Dublin 24.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 540/98/1

PA 540/98/2

PA 540/99/1


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

3rd June 1992 / 3rd June 2007

3rd June 1992 / 3rd June 2007

13th July 1989/3rd June 2007


Go to top of the page
10. DATE OF REVISION OF THE TEXT

July 2007.



Link to this document from your website:
http://www.medicines.ie/medicine/3446/SPC/Dioralyte/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Active Ingredients

 
   Potassium Chloride
   Sodium Chloride
   Glucose
   Disodium Hydrogen Citrate

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo